RARG and hepatocellular carcinoma: From studies of hepatocellular carcinoma cells, investigators argued that the anticancer action of acacetin does not depend on the modulation of RARγ-driven gene transcription and instead that RARγ controls the balance between AKT- and p53-mediated events.